U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1052C>G (p.Thr351Ser) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jun 20, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002265581.10

Allele description [Variation Report for NM_000492.4(CFTR):c.1052C>G (p.Thr351Ser)]

NM_000492.4(CFTR):c.1052C>G (p.Thr351Ser)

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1052C>G (p.Thr351Ser)
HGVS:
  • NC_000007.14:g.117540282C>G
  • NG_016465.4:g.79499C>G
  • NM_000492.4:c.1052C>GMANE SELECT
  • NP_000483.3:p.Thr351Ser
  • NP_000483.3:p.Thr351Ser
  • LRG_663t1:c.1052C>G
  • LRG_663:g.79499C>G
  • LRG_663p1:p.Thr351Ser
  • NC_000007.13:g.117180336C>G
  • NM_000492.3:c.1052C>G
  • NM_000492.4:c.1052C>G
  • P13569:p.Thr351Ser
Protein change:
T351S
Links:
UniProtKB: P13569#VAR_009899; dbSNP: rs1800086
NCBI 1000 Genomes Browser:
rs1800086
Molecular consequence:
  • NM_000492.4:c.1052C>G - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
Normal function

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000696818Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jun 20, 2024)
germlineclinical testing

PubMed (18)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens.

Dörk T, Dworniczak B, Aulehla-Scholz C, Wieczorek D, Böhm I, Mayerova A, Seydewitz HH, Nieschlag E, Meschede D, Horst J, Pander HJ, Sperling H, Ratjen F, Passarge E, Schmidtke J, Stuhrmann M.

Hum Genet. 1997 Sep;100(3-4):365-77.

PubMed [citation]
PMID:
9272157

A novel computational and structural analysis of nsSNPs in CFTR gene.

George Priya Doss C, Rajasekaran R, Sudandiradoss C, Ramanathan K, Purohit R, Sethumadhavan R.

Genomic Med. 2008 Jan;2(1-2):23-32. doi: 10.1007/s11568-008-9019-8. Epub 2008 May 14.

PubMed [citation]
PMID:
18716917
PMCID:
PMC2518663
See all PubMed Citations (18)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000696818.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (18)

Description

Variant summary: CFTR c.1052C>G (p.Thr351Ser) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 251742 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in CFTR causing Cystic Fibrosis (0.00019 vs 0.013), allowing no conclusion about variant significance. c.1052C>G has been reported in the literature in individuals affected with Cystic Fibrosis, CBAVD, chronic pancreatitis and diffuse bronchiectasis, without strong evidence of causality (Mercier_1993, Dork_1997, Schrijver_2005, Bienvenu_2010, de Cid_2010, Dal Maso_2013, Masson_2013, Trujillano_2013, Grangeia_2018, Rispoli_2020, da Silva Filho_2021). These reports do not provide unequivocal conclusions about association of the variant with disease. At-least two co-occurrences in cis with other pathogenic variants have been reported (e.g. CFTR c.3484C>T, p.Arg1162X; CFTR c.1521_1523del, p.Phe508del) (Mercier_1993, Dal Maso_2013), providing supporting evidence for a benign role. One of these reports was in an obligate carrier father of an individual with CF (in cis with p.Arg1162X, Mercier_1993) while the other was in an individual reportedly affected with CF who harbored a non-informative genotype attributed to a synonymous variant (p.Pro1290=) in trans (in cis with p.Phe508del, Del Maso_2013). At least two publications report experimental evidence evaluating an impact on protein function (Bergougnoux_2023, Bihler_2024). The variant did not show any deleterious impact on mRNA or protein expression and Western blot results were not suggestive of a folding defect. However, the most pronounced variant effect resulted in approximately 46% of normal chloride channel conductance relative to wild type (e.g. Bihler_2024). The following publications have been ascertained in the context of this evaluation (PMID: 20167849, 33572515, 23670503, 20059485, 9272157, 18716917, 29589582, 16128988, 23951356, 8477260, 25735457, 32185651, 15858154, 23687349, 32819855, 19812525, 36567205, 38388235). ClinVar contains an entry for this variant (Variation ID: 53174). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024